SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 89.71 |
| Enterprise Value ($M) | 105.63 |
| Book Value ($M) | 19.67 |
| Book Value / Share | 3.34 |
| Price / Book | 4.56 |
| NCAV ($M) | 3.30 |
| NCAV / Share | 0.56 |
| Price / NCAV | 27.22 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.73 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -1.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.51 |
| Current Ratio | 4.51 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 60.91 |
| Assets | 77.28 |
| Liabilities | 57.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 10.02 |
| Operating Income | -48.33 |
| Net Income | -47.41 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -38.43 |
| Cash from Investing | 37.79 |
| Cash from Financing | 7.58 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Kingdon Capital Management, L.l.c. | 5.90 | ||
| 13G/A | Maverick Capital Ltd | 9.90 | -89.52 | |
| 13G | M28 Capital Management LP | 7.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,457 | 9,803 | 14.86 | |
| 1,575 | 18,260 | 8.63 | |
| 10,584 | 36,504 | 28.99 | |
| 3,951 | 22,420 | 17.62 | |
| 3,482 | 20,198 | 17.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CPRX – Catalyst Pharmaceuticals, Inc. | CRBP – Corbus Pharmaceuticals Holdings, Inc. |
| CRDF – Cardiff Oncology, Inc. | CRVO – CervoMed Inc. |
| CSBR – Champions Oncology, Inc. |